Stock Down Under

Money-Making Insights On

ASX-Listed Stocks

Recent Articles

Evolution Mining (ASX:EVN) Reaches Net Cash After A$406m March Quarter: Buy, Hold or Wait?

April 15, 2026

Evolution Mining Clears Debt and…

Boss Energy (ASX:BOE) Production Downgrade, Rain-Driven Disruption, and Why FY27 Is Now the Test

April 15, 2026

Honeymoon guidance cut to 1.40-1.45M…

Nufarm (ASX:NUF) 17% EBITDA Jump, A$50m Cost Cut, and the De-leveraging Story Investors Missed

April 15, 2026

Net debt falls A$130m while…

Immutep (ASX:IMM) wins FDA orphan status as efti Phase 2 hits 51.5% endpoint

April 15, 2026

Rebound gains fuel as FDA…

Telix Pharmaceuticals (ASX:TLX) refinances with US$600m 2031 convert at 1.5% coupon

April 15, 2026

Raises US$600m in convertible debt,…

Stars And Stripes Income: The 6 Best American stocks for Australian investors in 2026!

April 15, 2026

Stocks Down Under recaps tha…

Sick Charts: Why The ASX’s 3 Pathology Stocks Are All Under the Weather

April 15, 2026

The ASX’s 3 pathology stocks:…

Michael Hill (ASX:MHJ): This Under Pressure Jewellery Outlet Is Trying To Position Itself As An AI Play

April 15, 2026

In this era, every company…

Why Stagflation Is Now a Real Risk for Australia and What It Means for Your ASX Portfolio

April 15, 2026

What Stagflation Means for Your…

Pro Medicus (ASX:PME) Banks A$80M in One Month: Is the 60% Selloff Finally a Buy?

April 15, 2026

Pro Medicus Secures A$80M Amid…

Cleanaway (ASX:CWY) Cuts A$20M From EBIT Six Weeks After Upgrading Guidance to A$500M

April 15, 2026

Cleanaway adjusts guidance: Fuel costs…

US Naval Blockade Is Live: 3 ASX Stocks That Win Whether the War Escalates or Ends

April 14, 2026

ASX stocks in focus as…

ASX Gambling & Gaming Stocks: Assessing the Best Investments

April 14, 2026

The global gambling and gaming…

ASX Investor Live: Strait of Hormuz Blockade, Why Geopolitics Is Now Driving ASX Returns

April 14, 2026

If you are wondering why…

IperionX (ASX:IPX) analysts see $9 target, but 2026 is about execution not earnings

April 14, 2026

GenX scale-up, Titan economics, customer…

PainChek (ASX:PCK) lands US$5B Sabra REIT, 20,000 beds worth A$1.5m

April 14, 2026

What PainChek Just Secured PainChek…

Investing in Qantas (ASX:QAN) in 2026, The Fuel Shock Investors Can’t Ignore

April 14, 2026

Investing in Qantas (ASX: QAN)…

PointsBet (ASX: PBH) is attempting a turnaround and the market is starting to believe it

April 14, 2026

PointsBet (ASX: PBH) has spent…

The Big Four Banks: Which is the best one for investors in 2026?

April 14, 2026

Australia’s Big Four Banks remain…

Here are 5 Recent AI Acquisitions on the ASX! But Are They Just Hype?

April 14, 2026

This article explores 5 Recent…

Find Us in

Stocks Down Under Analysts delve into a large variety of ASX-listed stocks and sectors.

Evolution Mining (ASX:EVN) Reaches Net Cash After A$406m March Quarter: Buy, Hold or Wait?

By Ujjwal Maheshwari | April 15, 2026

Evolution Mining Clears Debt and Hits Record Cash Flow Evolution Mining (ASX:EVN) jumped close to 10% today after delivering one of the most significant quarterly results in its history. The company generated A$406 million in cash flow for the March quarter and crossed into net cash territory for the first time. That means Evolution Mining…

Boss Energy (ASX:BOE) Production Downgrade, Rain-Driven Disruption, and Why FY27 Is Now the Test

By Charlie Youlden | April 15, 2026

Honeymoon guidance cut to 1.40-1.45M lbs as weather and infrastructure delays compound Boss Energy Limited’s (ASX:BOE) Honeymoon uranium operation in South Australia has had a difficult quarter, and the company has now formally revised its FY26 production guidance downward. What was previously a 1.6M lbs target has been reduced to a range of 1.40M to…

Nufarm (ASX:NUF) 17% EBITDA Jump, A$50m Cost Cut, and the De-leveraging Story Investors Missed

By Charlie Youlden | April 15, 2026

Net debt falls A$130m while a strategy reset quietly changes the earnings picture Nufarm Limited’s (ASX:NUF) first-half update landed this morning and the headline number is straightforward. Underlying EBITDA for the six months to 31 March 2026 is tracking between A$239m and A$244m, which is roughly 17% above the prior corresponding period at the midpoint.…

Immutep (ASX:IMM) wins FDA orphan status as efti Phase 2 hits 51.5% endpoint

By Charlie Youlden | April 15, 2026

Rebound gains fuel as FDA orphan tag backs 38-patient efti data Immutep (ASX:IMM) has received FDA orphan drug designation for eftilagimod alfa, or efti, in soft tissue sarcoma. This is not approval to sell the drug yet, but it is still a meaningful regulatory step because it recognises soft tissue sarcoma as a rare cancer…

Telix Pharmaceuticals (ASX:TLX) refinances with US$600m 2031 convert at 1.5% coupon

By Charlie Youlden | April 15, 2026

Raises US$600m in convertible debt, cuts refinancing risk ahead of Pixclara PDUFA Telix Pharmaceuticals (ASX:TLX) is sourcing US$600 million of convertible debt, replacing nearer-dated debt with a longer-dated instrument that reduces refinancing pressure and gives the company more room to stay focused on product launches. What stands out to us is the 1.5% coupon. That…

Stars And Stripes Income: The 6 Best American stocks for Australian investors in 2026!

By Nick Sundich | April 15, 2026

Stocks Down Under recaps tha Best American stocks for Australian investors! We know that many Australian investors look beyond the ASX for opportunities, and US equities remain the deepest and most liquid market in the world. What are the Best ASX Stocks to invest in right now? Check our buy/sell tips Practical considerations for investors…

Sick Charts: Why The ASX’s 3 Pathology Stocks Are All Under the Weather

By Nick Sundich | April 15, 2026

The ASX’s 3 pathology stocks: Sonic Healthcare (ASX:SHL), Healius (ASX:HLS) and Australian Clinical Labs (ASX:ACL); have delivered a torrid experience for shareholders over the past two to three years. Sonic, the global heavyweight, has fallen nearly 20% since early 2025 and recently traded at decade lows. Healius, long the sector’s problem child, has lost more…

Michael Hill (ASX:MHJ): This Under Pressure Jewellery Outlet Is Trying To Position Itself As An AI Play

By Nick Sundich | April 15, 2026

In this era, every company is trying to position itself as an AI play – even jewellery retailer Michael Hill (ASX:MHJ). Given the leadership vacuum with the deaths of former CEO Daniel Bracken and Sir Michael Hill, not to mention the subdued consumer environment…investors wouldn’t be condemned for asking: What now? The company just held…

Why Stagflation Is Now a Real Risk for Australia and What It Means for Your ASX Portfolio

By Ujjwal Maheshwari | April 15, 2026

What Stagflation Means for Your ASX Holdings Most economic problems have a straightforward solution. Growth slows too fast? The RBA cuts rates. Inflation runs too hot? The RBA hikes. Stagflation is different because it presents both problems at the same time, leaving the central bank with no clean answer. We believe Australia is now closer…

Pro Medicus (ASX:PME) Banks A$80M in One Month: Is the 60% Selloff Finally a Buy?

By Ujjwal Maheshwari | April 15, 2026

Pro Medicus Secures A$80M Amid 60% Selloff Pro Medicus (ASX:PME) jumped 4.3% on Monday after securing a A$37 million contract renewal with Northwestern Medicine at higher per-exam fees than its original deal. That single win pushed total contract announcements to nearly A$80 million in just one month. Yet the stock still trades around A$132, down…

Sector Analysis

The-Best-Mining-Stocks

The Best Mining Stocks

Mining and resources stocks have substantial potential given demand for all types of resources and metals from gold and iron ore to battery metals like lithium and graphite! There are over 700 stocks in this sector from big miners to small cap explorers.

The-Best-Tech-Stocks

The Best Tech Stocks

Tech stocks are appetising in the context of an increasingly digital world ranging from data centre builders, cloud services providers and cybersecurity companies. Many of the ASX's best performing stocks in the last decade have been tech stocks.

The-Best-Uranium-Stocks

The Best Uranium Stocks

Uranium stocks are in a good spot right now with rising demand for clean energy, nuclear energy making a comeback and yellowcake pricing reaching levels not seen since the GFC. This has enabled many companies with mothballed projects to bring them out of hibernation.

Untitled design

The Best Healthcare Stocks

There are dozens of Healthcare stocks on the ASX ranging from big names like CSL and Cochlear with established products and markets, to small cap biotechs and medtechs hoping to follow in their footsteps and commercialise the next big innovation.

The-Best-Mining-Stocks

The Best Mining Stocks

The-Best-Tech-Stocks

The Best Tech Stocks

The-Best-Uranium-Stocks

The Best Uranium Stocks

Share Type Analysis

The Best ASX Stocks Right Now

The Best ASX Stocks Right Now

The quest for the best stocks to buy now is a never-ending one, but armed with a solid investment strategy, you can create a diversified portfolio that stands the test of time. We provide our Top 10 ASX stocks we think investors should consider right now. 

The Best ASX Stocks Right Now

The Best ASX Stocks Right Now

The Top Penny Stocks

The Top Penny Stocks

Navigating ASX Penny stocks, can be complex, given the diversity of companies operating in various sectors and the high risk associated with them. But there is potential for impressive returns if investors can find the right company.

The Top Penny Stocks

The Top Penny Stocks

The Top Dividend Stocks

The Top Dividend Stocks

Investing in Dividend stocks can provide an additional source of income, and so are popular with a wide variety of investors. But only some companies pay dividends, and even consistent payers can fluctuate payouts year to year. We outline the Top Dividend Stocks for investors to consider.

The Top Dividend Stocks

The Top Dividend Stocks

size set 1

Top ASX Index Funds

Explore our comprehensive analysis of the top ASX index funds, carefully curated by industry experts. Discover which funds are currently outperforming and why, based on detailed market trends and performance metrics. Ideal for both new and seasoned investors seeking strategic investment opportunities on the ASX. Dive into our report today to make informed investment decisions.

size set 1

Top ASX Index Funds

size 2

The Top Blue Chip Stocks

Discover the best ASX blue chip stocks for investment. Our industry experts provide in-depth analysis on these well-established companies with strong credit ratings and a long history of performance and stability. Explore market leaders like Commonwealth Bank of Australia, BHP Group Ltd, and National Australia Bank Limited.

size 2

The Top Blue Chip Stocks

size 3

Top ASX Growth Stocks for Investing

Explore our comprehensive analysis of the top ASX growth stocks for investing. Our industry experts have curated a detailed report on the most promising opportunities available in the market. Whether you're a seasoned investor or just starting out, our insights provide valuable information to help you make informed decisions.

size 3

Top ASX Growth Stocks for Investing

Webinars and Interviews

Environmental Clean Technologies (ASX:ECT) uses Flash Joule Heating for soil remediation

Environmental Clean Technologies (ASX:ECT) We spoke with Justin Sharp, CEO of Environmental Clean Technologies, about the…

Archer Materials presented at the Pitt Street Research Semiconductor Conference 2026

Archer Materials (ASX:AXE) Archer Materials‘ CEO Simon Ruffell presented at the 2026 edition of the Pitt…

Nanoveu presented at the Pitt Street Research Semiconductor Conference 2026

Nanoveu (ASX:NVU) Nanoveu’s EMASS founder Mohamed Sabry presented at the 2026 edition of the Pitt Street…

Weebit Nano presented at the Pitt Street Research Semiconductor Conference 2026

Weebit Nano (ASX:WBT) Weebit Nano‘s CEO Coby Hanoch presented at the 2026 edition of the Pitt…

Investment Glossary

What Is a Small Cap Company? A Complete Guide for Investors

September 24, 2024

Overview of Small Cap Companies…

What is the All Ordinaries Index and How Does It Work?

September 20, 2024

The All Ordinaries Index, also…

What is Commodity? Understanding Commodity Trading

May 23, 2024

Introduction to Commodities Commodities are…

Overview of Securities in the Australian Financial Market

May 23, 2024

What is a security? Security refers…

What Is an IPO? Understanding Initial Public Offerings

May 23, 2024

What is IPO? An Initial Public…

The Team Behind Stocks Down Under

1rw

Stuart Roberts

Co-Founder

Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research

Marc-circle-300x300_webp

Marc Kennis

Co-Founder

Marc is the co-founder of Stocks Down Under and has 25+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research,

The Team Behind Stocks Down Under

STUART ROBERTS

Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research together with Marc.

MARC KENNIS

Marc is the co-founder of Stocks Down Under and has 20+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research, Australia's preeminent issuer-sponsored equities research firm.

PETER KILBY

Pete is Stocks Down Under's head of customer service. He is an avid investor with a knack for deep-dive company research. Pete likes the more established companies on ASX, but doesn't shy away from the occasional risky play. At Stocks Down Under he gets to do the two things he loves most, investing and talking to like-minded people.

Please enter your name.
Please enter a message.